Charles S. Ryan's Net Worth
-$39.5 Thousand
Who is Charles S. Ryan?
Charles S. Ryan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Quince Therapeutics, Inc., BioRestorative Therapies, Inc., APPLIED DNA SCIENCES INC, and Neurotrope, Inc..
SEC CIK
Charles S. Ryan's CIK is 0001624830
Past Insider Trading and Trends
2019 was Charles S. Ryan's most active year for acquiring shares with 8 total transactions. Charles S. Ryan's most active month to acquire stocks was the month of February. 2019 was Charles S. Ryan's most active year for disposing of shares, totalling 5 transactions. Charles S. Ryan's most active month to dispose stocks was the month of February. 2017 saw Charles S. Ryan paying a total of $105,001.80 for 360,457 shares, this is the most they've acquired in one year. In 2020 Charles S. Ryan cashed out on 557,695 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Quince Therapeutics, Inc. (QNCX) Snapshot price: $0.71
PRESIDENT
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +65.32% | 48.39K |
$0.65 | $31,451.55 | 122.46K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BioRestorative Therapies, Inc. (BRTX) Snapshot price: $1.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
| +164.10% | 26.67K |
$3.00 | $80,001.00 | 42.92K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
| +62.50% | 6.25K |
$4.00 | $25,000.00 | 16.25K |
Dec 7
| |||
Form 4
|
∞
| 200K |
$0.25 | $50,000.00 | 200K |
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
APPLIED DNA SCIENCES INC (APDN) Snapshot price: $1.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
∞
| 14.21K |
$1.76 | $25,000.80 | 14.21K |
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neurotrope, Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||